The FDA has granted quick monitor designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinomaThe U.S....
Anemia and gastrointestinal bleeding are among the many most typical signs for sufferers with gastrointestinal stromal tumors (GIST), defined Dr. Rosario Ligresti, chief...
Early trial outcomes report progression-free survival and response charges for ateganosine, spevatamig, Annamycin and pumitamig; research are at present enrolling.CURE’s Scientific Trial Nook...
